First-of-its-kind study explores whether stem cells might lessen inflammation in CF patients

A team of researchers at University Hospital’s Rainbow Babies & Children’s Hospitals are conducting the first ever stem cell trial for cystic fibrosis (CF). Researchers will follow trial participants who receive a single infusion of human mesenchymal stem cells for a year to ensure the safety of the treatment. The goal of the trial is […]

Continue reading


Texas Congressman Pete Olson dedicates vote for 21st Century Cures Act in honor of Celltex client Sarah Hughes

The U.S. House of Representatives overwhelmingly passed the 21st Century Cures Act on Wednesday, November 30. The bill, which had widespread bipartisan support, will work to promote medical innovation, speed, and access to new drugs and will provide a breakthrough for medical research funding. The bill also includes provisions that address the advancement of regenerative […]

Continue reading


Celltex Client Shares Stem Cell Journey with Congressman Pete Olson

Houston resident and Celltex client, Sarah Hughes, shared her inspiring adult stem cell journey with Congressman Pete Olson on Wednesday, October 5, 2016. Olson, who represents the 22nd district of Texas, is a major supporter of the 21st Century Cures Act and has been following Sarah’s transformation before and after stem cell therapy. Sarah, who most recently […]

Continue reading


Celltex welcomes football legends to share stem cell journey at seminar in Georgetown

Celltex was honored to welcome football legends Bob “Mr. Cowboy” Lilly and Jackie Sherrill to a seminar on Tuesday, October 25, 2016 at Berry Creek Country Club in Georgetown, Texas. Bob Lilly, former defensive tackle for the Dallas Cowboys and Jackie Sherrill, former head football coach at University of Pittsburg, Texas A&M University, and Mississippi […]

Continue reading


Celltex clients address FDA during two-day hearing on stem cell regulation

The U.S. Food and Drug Administration (FDA) held its much-anticipated hearing on the regulation of human cells, tissues and cellular and tissue-based products (HCT/Ps) on September 12-13, 2016, where it received public comment from hundreds of individuals, including three clients of Houston-based biotechnology company Celltex Therapeutics Corporation. Samantha Wilkinson, Sarah Hughes and her mother, Fiona […]

Continue reading


Celltex Client Shares Stem Cell Journey with San Antonio Seminar Attendees

San Antonio resident and Celltex client, Stefanie Cowley, shared her inspiring stem cell journey with attendees of the Celltex San Antonio seminar on August 10. Cowley, who was diagnosed with multiple sclerosis in February of 2007, shared the difficulties of MS that ultimately led her to contact Celltex Therapeutics in 2014. Celltex clients Stefanie Cowley […]

Continue reading


Implications profound for neurological diseases from autism to Alzheimer’s to multiple sclerosis

Researchers at the University of Virginia School of Medicine have found that the brain is directly connected to the immune system by vessels previously thought not to exist. This startling discovery could drastically change the treatment of neurological diseases ranging from autism to Alzheimer’s disease to multiple sclerosis. The vessels, which had previously escaped detection […]

Continue reading


Frozen adipose-derived mesenchymal stem cells maintain high capability to grow and differentiate

Researchers from Switzerland and Italy have found that adipose-derived stromal cells (ASCs) frozen in liquid nitrogen for future needs, maintain their viability. Researchers discovered that once these frozen cells (the same types of cells used by Celltex) have thawed, they are able to maintain full capability to grow and differentiate into culture. This discovery is […]

Continue reading